Patent Assignment
Reel/Frame 038953/0312
Confirmatory Assignment
Recorded: 2016-06-10
Pages: 18
Assignor
UCB PHARMA, S.A.
Executed: 2015-12-08
Assignee
UCB BIOPHARMA SPRL
60 ALLEE DE LA RECHERCHE, BRUSSELS, B-1070, BELGIUM
Covered Properties
(76)
E.Coli Host Cells with Modified Phos/Psts Periplasmic Phosphate-Binding Proteins, and Method of Manufacturing Recombinant Fabs
Assay for Identifying Antibody Producing Cells
Antibody Molecules Having Specificity for Human Il-1 Beta
Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
Methods for Producing Antibodies
Modified Antibody Fab Fragments
Methods for the Treatment of Inflammatory Bowel Disease By Administration of an Inhbitor of CSF-1 Activity
Application:
10/578,384 →
Publication:
US 2007/0148172
Branched Molecular Scaffolds for Linking Polymer Residues to Biologically Active Moieties
Pharmaceutical Composition Of Piperazine Derivatives
Benzoxazolone Derivatives, Processes for Preparing Them and Their Uses
Indolone Derivatives, Processes for Preparing Them and Their Uses
Cross-Linked Antibodies
Albumin-Binding Conjugates Comprising a Fatty Acid and Peg
Neutralising Antibody Molecules Having Specificity for Human Il-17
Anti-Tnf Alpha Antibodies Which Selectively Inhibit Tnf Alpha Signalling Through the P55R
Pharmaceutical Compositions Comprising Levetiracetam and Process for Their Preparation
Method for Obtaining Antibodies
Fused Thiazole Derivatives as Kinase Inhibitors
2-Oxo-1-Pyrrolidine Derivatives
2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
2-Oxo-1-Pyrrolidine Derivatives, Processes For Preparing Them And Their Uses
Process for Attaching Effector Molecules to Proteins
Modified Antibody Fragments
Comb Polymers
Expression Control Using Antibody Expression Optimisation Sequences
Method for the Treatment of Multiple Sclerosis by Inhibiting Il-17 Activity
Co-Crystals of Pyrrolidinones
Fused Thiophene Derivatives as Kinase Inhibitors
Fused Thiazole Derivatives as Kinase Inhibitors
Antibody Molecules Which Bind to Human Il-17
Single Chain FC Polypeptides
Altered Antibodies
Antibody Molecules Which Bind Il-17A and Il-17F
Antibody Molecules Having Specificity for Human Il-1B
Indolone-Acetamide Derivatives, Processes for Preparing Them and Their Uses
Fused Thiazole Derivatives as Kinase Inhibitors
Dual Specificity Antibody Fusions
Quinoxaline and Quinoline Derivatives as Kinase Inhibitors
Antibodies Specific to IL-17A and IL-17F
Pharmaceutical Compositions Comprising Brivaracetam
Fused Pyridine Derivatives as Kinase Inhibitors
Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivate
Prolonged Release Formulations Comprising an 2-Oxo-1-Pyrrolidine Derivative
Pharmaceutical Compositions Comprising 2-Oxo-1-Pyrrolidine Derivatives
Application:
13/144,895 →
Publication:
US 2011/0275693
Pharmaceutical Compositions Comprising Brivaracetam
Method for Producing Protein
Fused Pyridine and Pyrazine Derivatives as Kinase Inhibitors
Method for Producing Proteins
Method for Producing Proteins
Application:
13/203,202 →
Publication:
US 2011/0313138
Nucleic Acid Molecules Encoding Neutralising Antibodies Having Specificity for Human Il-17
DNA Encoding Antibody Molecules Which Bind Human IL-17
Triazine Derivatives as Kinase Inhibitors
Multivalent Antibodies
Application:
13/395,235 →
Publication:
US 2012/0283415
2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
Co-Crystals of Pyrrolidinones
Multivalent Antibody Fusion Proteins
Application:
13/498,017 →
Publication:
US 2012/0316324
2-Oxo-1-Pyrrolidinyl Imidazothiadiazole Derivatives
Quinoline Derivatives as Kinase Inhibitors
Quinoline Derivatives as Kinase Inhibitors
Multivalent Antibodies
Application:
13/510,165 →
Publication:
US 2013/0066054
Multivalent Antibodies
Application:
13/521,818 →
Publication:
US 2013/0053549
Disulfide Stabilized Antibodies and Fragments Thereof
Disulfide Stabilized Dvd-Ig Molecules
Fused Thiazole Derivatives as Kinase Inhibitors
Neutralising Antibody Molecules Having Specificity for Human IL-17
Antibodies of the Class IGG4
Quinoline Derivatives as Kinase Inhibitors
Nucleic Acids Encoding Antibody Molecules Which Bind IL-17A and IL-17F
Application:
14/035,053 →
Publication:
US 2014/0044732
2-Oxo-1-Imidazolidinyl Imidazothiadiazole Derivatives
Antibodies Specific to Il-17A and Il-17F
2-Oxo-Piperidinyl Derivatives
Sequence Symmetric Modified IGG4 Bispecific Antibodies
Sequence Asymmetric Modified IgG4 Bispecific Antibodies
Methods for Treating Parkinson's Disease
Recombinant Bacterial Host Cell for Protein Expression
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 15, 2005
From: BROWN, DEREK THOMAS; BUTLER, LISA; CROMIE, KAREN DOROTHY; GRIFFITHS, MERYN RUTH
To: CELLTECH R&D LIMITED
Reel/Frame 017126/0092 →
Assignment of Assignor's Interest
Jan 19, 2006
From: LAWSON, ALASTAIR DAVID GRIFFITHS; POPPLEWELL, ANDREW GEORGE
To: CELLTECH R&D LIMITED
Reel/Frame 017203/0815 →
Assignment of Assignor's Interest
Jan 26, 2006
From: STARCK, JEAN-PHILIPPE; KENDA, BENOIT
To: UCB S.A.
Reel/Frame 017212/0440 →
Assignment of Assignor's Interest
Mar 30, 2006
From: HUMPHREYS, DAVID PAUL; CHAPMAN, ANDREW PAUL; ROBINSON, MARTYN KIM; SPITALI, MARIANGELA
To: CELLTECH R & D LIMITED
Reel/Frame 017412/0167 →
Assignment of Assignor's Interest
Jun 15, 2006
From: HUMPHREYS, DAVID PAUL; HEYWOOD, SAM PHILIP
To: CELLTECH R & D LIMITED
Reel/Frame 017802/0455 →
Assignment of Assignor's Interest
Jun 20, 2006
From: LAWSON, ALASTAIR DAVID GRIFFITHS; LIGHTWOOD, DANIEL JOHN
To: CELLTECH R&D LIMITED
Reel/Frame 017826/0984 →
Assignment of Assignor's Interest
Jan 18, 2007
From: NORMAN, TIMOTHY JOHN
To: CELLTECH R & D LIMITED
Reel/Frame 018784/0645 →
Assignment of Assignor's Interest
Jan 18, 2007
From: LAWSON, ALASTAIR DAVID GRIFFITHS; BOURNE, TIMOTHY
To: CELLTECH R & D LIMITED
Reel/Frame 018783/0396 →
Assignment of Assignor's Interest
Mar 9, 2007
From: KENDA, BENOIT; STARCK, JEAN-PHILIPPE
To: UCB PHARMA, S.A.
Reel/Frame 018988/0418 →
Assignment of Assignor's Interest
Apr 10, 2007
From: STARCK, JEAN-PHILIPPE; KENDA, BENOIT
To: UCB, S.A.
Reel/Frame 019142/0061 →
Assignment of Assignor's Interest
Jul 5, 2007
From: EATON, MICHAEL ANTHONY WILLIAM; NORMAN, TIMOTHY JOHN; PORTER, JOHN ROBERT
To: CELLTECH R & D LIMITED
Reel/Frame 019518/0116 →
Assignment of Assignor's Interest
Jul 26, 2007
From: FANARA, DOMENICO; SCOUVART, JEAN; POULAIN, CLAIRE; DELEERS, MICHEL
To: UCB, S.A.
Reel/Frame 019613/0903 →
Corrective Assignment to Correct the Incorrect Serial Number from 10/596,654 to 11/596,654. Document Previously Recorded at Reel 019517 Frame 0500.
Jul 31, 2007
From: BAKER, TERENCE SEWARD; MCKAY, CATHERINE; NORMAN, TIMOTHY JOHN; PORTER, JOHN ROBERT
To: CELLTECH R & D LIMITED
Reel/Frame 019663/0466 →
Assignment of Assignor's Interest
Oct 17, 2007
From: ADAMS, RALPH; POPPLEWELL, ANDREW GEORGE; RAPECKI, STEPHEN EDWARD; TICKLE, SIMON PETER
To: UCB PHARMA S.A.
Reel/Frame 019976/0134 →
Assignment of Assignor's Interest
Oct 17, 2007
From: BROWN, DEREK THOMAS; KIRBY, HISHANI; FINNEY, HELENE MARGARET; LAWSON, ALASTAIR DAVID GRIFFITHS
To: UCB PHARMA S.A.
Reel/Frame 019976/0798 →
Assignment of Assignor's Interest
Oct 25, 2007
From: LAWSON, ALASTAIR DAVID GRIFFITHS
To: UCB PHARMA S.A.
Reel/Frame 020017/0723 →
Assignment of Assignor's Interest
Jun 23, 2008
From: DELEERS, MICHEL; HUBERT, JEAN-BENOIT
To: UCB PHARMA, S.A.
Reel/Frame 021134/0394 →
Con
Sep 4, 2008
From: CELLTECH R&D LIMITED
To: UCB PHARMA S.A.
Reel/Frame 021478/0274 →
Assignment of Assignor's Interest
Nov 12, 2008
From: UCB, S.A.
To: UCB PHARMA, S.A.
Reel/Frame 021823/0435 →
Assignment of Assignor's Interest
Oct 13, 2009
From: CELLTECH R&D LIMITED
To: UCB PHARMA S.A.
Reel/Frame 023363/0525 →
Assignment of Assignor's Interest
Oct 13, 2009
From: MARSHALL, DIANE
To: CELLTECH R&D LIMITED
Reel/Frame 023363/0463 →